Pleurodesis outcome in malignant pleural mesothelioma

Edward Fysh, S.K. Tan, C.A. Read, F. Lee, K. Mckenzie, Nola Olsen, I. Weerasena, T. Threlfall, Nicholas De Klerk, Arthur Musk, Gary Lee

Research output: Contribution to journalArticlepeer-review

44 Citations (Scopus)


Few data exist on the pleurodesis outcome in patients with malignant pleural mesothelioma (MPM). A retrospective review of the Western Australian Mesothelioma Registry over 5 years revealed 390 evaluable patients. Only a subset of patients (42.3%) underwent pleurodesis, surgically (n=78) or by bedside instillation of sclerosants (n=87). Surgical pleurodesis showed no advantages over bedside pleurodesis in efficacy (32% vs 31% failures requiring further drainage, p=0.98), patient survival (p=0.52) or total time spent in hospital from procedure till death (p=0.36). No clinical, biochemical or radiographic parameters tested adequately predict pleurodesis outcome.
Original languageEnglish
Pages (from-to)594-596
Issue number6
Publication statusPublished - 2013


Dive into the research topics of 'Pleurodesis outcome in malignant pleural mesothelioma'. Together they form a unique fingerprint.

Cite this